Intervention

Placebo 300mg

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions6

Lead sponsors shown2

Clinical trials

2 shown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid ArthritisNCT03755258 · 2017-03-16

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursNCT02804815 · 2015-10-01

ACTIVE_NOT_RECRUITING

Common conditions

Breast Cancer1 Cancer1 Colorectal Cancer1 Early Rheumatoid Arthritis1 Gastro-oesophageal Cancer1 Prostate Cancer1

Leading sponsors

University College, London1 Zhejiang Hisun Pharmaceutical Co. Ltd.1

Trial status mix

ACTIVE_NOT_RECRUITING1

UNKNOWN1

Phase mix

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.